Arcutis Biotherapeutics Clinical Site 115 — High Point, North Carolina

Arcutis Biotherapeutics Clinical Site 115 is a clinical research site located in High Point, North Carolina, United States 27262.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Arcutis Biotherapeutics Clinical Site 115 has participated in 2 clinical trials.

Therapeutic areas: Chronic Plaque Psoriasis.

Sponsors: Arcutis Biotherapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Arcutis Biotherapeutics Clinical Site 115?

Arcutis Biotherapeutics Clinical Site 115 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Arcutis Biotherapeutics Clinical Site 115 conducted?

Arcutis Biotherapeutics Clinical Site 115 has 2 clinical trials on record. Their work covers Chronic Plaque Psoriasis.

Is Arcutis Biotherapeutics Clinical Site 115 accredited by Crixeo Health?

Arcutis Biotherapeutics Clinical Site 115 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Arcutis Biotherapeutics Clinical Site 115?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.